Company: BAYAU
Filing Date: 2025-04-01
Form Type: 10-K
Source: 0001641172-25-002125
Chunk: 52

Company: Bayview Acquisition Corp
Filing Date: 2025-04-01
Form: 10-K
Item: Item 1
Chunk 52
---
 negative impact on the market price of our Ordinary
Shares that is expected when the Ordinary Shares and Private Placement Units owned by our founders or holders of our working capital
units or their respective permitted transferees are registered.

  28 

In
order to complete our initial business combination, we may seek to amend our Second Amended and Restated Memorandum and Articles of Association
or other governing instruments, including our rights agreement, in a manner that will make it easier for us to complete our initial business
combination but that our shareholders or rights holders may not support.

In
order to complete a business combination, blank check companies have, in the recent past, amended various provisions of their charters
and governing instruments, including their rights agreement. For example, blank check companies have amended the definition of business
combination, increased redemption thresholds, changed industry focus and, with respect to their Rights, amended their rights agreements
to require the Rights to be exchanged for cash and/or other securities. We cannot assure you that we will not seek to amend our charter
or other governing instruments or change our industry focus in order to complete our initial business combination.

Our
founders contributed an aggregate of approximately $25,100, or approximately $0.02 per Founder Share, and, accordingly, you will experience
immediate and substantial dilution from the purchase of our Ordinary Shares.

The
difference between the public offering price per share (allocating all of the unit purchase price to the Ordinary Shares and none to
the Rights included in the Units) and the pro forma net tangible book value per our Ordinary Shares after the IPO constitutes the dilution
to you and the other investors in the IPO. Our founders acquired the Founder Shares at a nominal price, significantly contributing to
this dilution. Upon the closing of the IPO, and assuming no value is ascribed to the Rights included in the Units, you and the other
public shareholders will incur an immediate and substantial dilution of approximately 107% (or $9.73 per share, assuming no exercise
of the underwriters’ over-allotment option), the difference between the pro forma net tangible book value per share of $(0.64)
and the initial offering price of $10.00 per unit. In addition, because of the anti-dilution rights of the Founder Shares, any equity
or equity-linked securities issued in connection with our initial business combination would be disproportionately dilutive to our Ordinary
Shares.

Our
founders paid an aggregate of $25,